At the close of each quarter, the U.S. Market Access Center of Excellence publishes a Quarterly Advisor featuring a series of articles on the latest Market Access insights. In this edition, we review 340B drug discount program growth drivers, the emergence of formulary exclusions in oncology, and contract compliance reviews. Download the Q3 Advisor today.